Summary: This paper presents the results of a joint European external quality control survey for thyrotropin determinations in blood dried on filter paper, carried out in 1986 in cooperation with several national quality control organizations. For the evaluation, 124 participants presented their individual diagnostic classifications in addition to their analytical results. Although, in relation to earlier studies of this kind, there was a significant improvement in interlaboratory precision the results still showed variance which depended on the analytical method and, possibly on the country in which it was performed. Regional differences were also evident in the diagnostic classifications.
Introduction
On the 5th. and 6th. December, 1984, a Symposium was held in Lilie, France on the subject of "Neonatal Screening and Quality Control". One of the results of the Symposium was a plan to carry out annually a joint European quality control survey pf screening analyses for hypothyroidism and phenylketonuria.
The first joint Eürppeän external quality control survey of thyrotropin determinations was conducted by the French Organisation for external quality assessment in December 1985, the second by the "Deutsche Gesellschaft für Klinische Chemie" in June 1986. The ÜK External Quality Assessment Scheine for Thyroid-related Hormones is riow preparing a third one for September 1987.
The present paper reports on the results of the second joint European quality control survey.
Materials and Methods

Control specimens
As samples, the participants each received 4 cards of filter paper (Schleicher & Schüll 2992) with 3 drops of dried blood each. The desired thyrotropin concentrations were attained by adding the Ist reference preparation 1974 (68/38) to whole blppd containing low thyrotropin concentrations (haematocrit-corrected). The analyses were carried out from June 9 to 21, 1986.
Documentation of the results and findings
Together with control samples, the participants in the quality control surveys received a registration form. The results of two single determinations and their mean in mU per l of blood were entered on these forms. In addition, a diagnostic classification of the analysis result was required:
1) normal 2) a case of congenital hypothyroidism possibly or 3) probably pathologic.
Further, when a commerciaily available test kit had been used for the determinations, the name of the kit producer was requested.
Evaluation
After the results had been collected, evaluation was then begun with the help of electronic data processing. The mean of the individual estimations for each double determination was data processed äs the analysis result.
Changes made after the first evaluation of the survey had been sent out to the participants:
Four participants had cited the thyrotropin concentration in serum instead of in blood, äs was indicated in the experiment instructions. As a result of Information handed in at a later date, the readings from these participants were halved for this present evaluation. Moreover, now included are four additional participants whose results had arrived too late for initial evaluation.
In order to detect pössible correlations, the results were divided into 2 sub-groups: 1) Those that had worked with the same commercial kits and 2) those from the same country (excepting a small number of laboratories from countries in the subgroup "others")
The median of the values served to establish the location parameter of the collective values, and the distance between the 25%-75% and the 16%-84% percentiles, respectively, served to describe the dispersion.
Results and Discussion
124 laboratories sent in their analysis results for evaluation. The analysis methods applied are based on the analytic pfinciples for determining thyrotropin in dried blood that were developed in the seventies (l, 2). According to the particulars given by the participants, 21 of them üsed modifications they had developed themselves, 88 carried out the analysis with test kits from 12 different and named manufacturers, while 15 used other kits ör gave no data (tab. 1).
In agreement with earlier studies (3, 4), there were again no essentiäl differences between the tatget values and the medians of all the results (tab. 2). Interlaboratory precision, however, had significantly improved, äs can be seen by comparing the relative deviatioiis of 16% and of 84% percentiles with the corresponding values from past external quality control surveys. This trend toward greater precision, already apparent äs early äs 1983, therefore continues for these semi-quantitative deternuiiaticms (5).
An important reason föf this improvement seems to be that the differences in results now depend less on which kit is used (6 Fig. 1 . Medians of results from at least six laboratories using the same commercial kits for 4 diflferent thyrotropin specimens.
The numbers in the figure are the code numbers according to However, a first glance still gives the impression that the type of kits used played a leading role in the results. Although the medians öf the results from France agf eed very well in 3 out of 4 cases with the target values, it is otherwise conspicuous that in France where 18 from 21 laboratories used kit No. 30 and in Italy where 5 from 13 laboratories preferred kit No. 76, the highest values, almost without exception, were recorded. As no comparative values for other known kits were available for France, it is not possible to decide whether higher values were due to the kit or to the region. The results from Italy --where different kits were used -at least do not exclude the possibility that regional factors, whatever they may be, could have played a role. Of their 52 results, only 11 were below the medians of all the participants; and with kit No. 18 the medians for Italy were äs much äs 4 mU/1 (specimen 3) higher than for the Federal Republic of Germany.
Much more homogeneous than the analysis results were the diagnostic classifications which the participants derived from them ( fig. 2) . For specimens l, 2 and 4, only a few participants cited a classificationeither "normal'' or "possibly/probably pathological" -which deviated from the majority. These few divergent classifications could be due to grave, analytical errors. It is a different case for the classification of the specimen in which the thyrotropin concentration (25 mU/1) is close to the decision limit, set most frequently at around 20 mU/1 by the laboratories (3). Here, äs a result of unavoidable analytic dispersion, there should have been a higher proportion of divergent classifications. It was therefore remarkable when a considerable number of French laboratories listed this classification äs "normal", although only one of them detect cases of congenital hypothyroidism, the queshad found a value under 20 mU/1. The decision limit tion arises of whether a higher value should not be is apparently allowed a higher ränge in France than agreed on in the interest of coordinating the settings in most other countries; in the Federal Republic of for decision limits. This was suggested in 1983 by Germany it is set at a maximum 20 mU/1. As there Wieland & v. Reuss, in order to reduce the number of is no evidenee that French screening often fails to superfluous, data-seeking tests on patients.
